Changes in guideline-recommended medication possession after implementing Kendra's Law in New York

Psychiatric Services

Volumn 61, Issue 10, 2010, Pages 1000-1005

  Busch, Alisa B ^a,b   Wilder, Christine M ^d   Van Dorn, Richard A ^c   Swartz, Marvin S ^d   Swanson, Jeffrey W ^d  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; ETHNICITY; FEMALE; HUMAN; KENDRA LAW; LAW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL PATIENT; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROBABILITY; RECOMMENDED MEDICATION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT INDICATION; FORENSIC PSYCHIATRY; INSURANCE; LEGAL ASPECT; MENTAL DISEASE; MIDDLE AGED; PATIENT COMPLIANCE; STATISTICAL MODEL; UNITED STATES;

ADULT; COMMITMENT OF MENTALLY ILL; HUMANS; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MEDICATION ADHERENCE; MENTAL DISORDERS; MENTALLY ILL PERSONS; MIDDLE AGED; NEW YORK; PATIENT COMPLIANCE;

EID: 85047687543     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2010.61.10.1000     Document Type: Article

References (37)

1. Swartz MS, Monahan J: Special section on involuntary outpatient commitment: introduction. Psychiatric Services 52:323-324, 2001 (Pubitemid 32259664)
2. Monahan J, Swartz M, Bonnie RJ: Mandated treatment in the community for people with mental disorders. Health Affairs 22(5):28-38, 2003 (Pubitemid 41388719)
3. Committee for Persons in Recovery: US Psychiatric Rehabilitation Association Position Paper on Involuntary Outpatient Commitment. Linthicum, Md, US Psychiatric Rehabilitation Association, 2007
4. Keilitz I: Empirical studies of involuntary outpatient civil commitment: is it working? Mental and Physical Disability Law Reporter 14:368-379, 1990
5. Swartz M, Swanson J, Hiday V, et al: A randomized controlled trial of outpatient commitment in North Carolina. Psychiatric Services 52:325-329, 2001 (Pubitemid 32259665)
6. Steadman H, Gounis K, Dennis D, et al: Assessing the New York City involuntary outpatient commitment pilot program. Psychiatric Services 52:330-336, 2001 (Pubitemid 32259666)
7. Swartz MS, Burns BJ, Hiday VA, et al: New directions in research on involuntary outpatient commitment. Psychiatric Services 46:381-385, 1995
8. Gilbert AR, Moser LL, Van Dorn RA, et al: Reductions in arrest under assisted outpatient treatment in New York. Psychiatric Services 61:996-999, 2010
9. Van Dorn RA, Swanson JW, Swartz MS, et al: Continuing medication and hospitalization outcomes after assisted outpatient treatment in New York. Psychiatric Services 61:982-987, 2010
10. Swanson JW, Van Dorn RA, Swartz MS, et al: Robbing Peter to pay Paul: did New York State's outpatient commitment program crowd out voluntary service recipients? Psychiatric Services 61:988-995, 2010
11. Robbins PC, Keator KJ, Steadman HJ, et al: Regional differences in New York's assisted outpatient treatment program. Psychiatric Services 61:970-975, 2010
12. Gilmer TP, Dolder CR, Lacro JP, et al: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161:692-699, 2004 (Pubitemid 38445514)
13. Sajatovic M, Valenstein M, Blow F, et al: Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatric Services 58:855-863, 2007 (Pubitemid 46985180)
14. Valenstein M, Copeland LA, Blow FC, et al: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care 40:630-639, 2002
15. Valenstein M, Ganoczy D, McCarthy JF, et al: Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. Journal of Clinical Psychiatry 67:1452-1550, 2006
16. Weiden PJ, Kozma C, Grogg A, et al: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55:886-891, 2004 (Pubitemid 39025215)
17. Recipients Under Court Order, by Region. New York, New York State Office of Mental Health, 2007. Available at http://bi.omh.state.ny.us/aot/statistics?p= under-court-order
18. Lurie N, Popkin M, Dysken M, et al: Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital and Community Psychiatry 43:69-71, 1992
19. Unützer J, Simon G, Pabiniak C, et al: The treated prevalence of bipolar disorder in a large staff-model HMO. Psychiatric Services 49:1072-1078, 1998 (Pubitemid 28363829)
20. Unützer J, Simon G, Pabiniak C, et al: The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO. General Hospital Psychiatry 22:1-10, 2000 (Pubitemid 30129086)
21. American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry 159(Apr suppl):1-50, 2002
22. Bauer MS, Callahan AM, Jampala C, et al: Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. Journal of Clinical Psychiatry 60:9-21, 1999 (Pubitemid 29069880)
23. Keck PE Jr, Perlis RH, Otto MW, et al: Expert Consensus Series: Treatment of bipolar disorder 2004. Postgraduate Medicine Special Report December:1-120, 2004
24. Lehman AF, Kreyenbuhl J, Buchanan RW, et al: The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophrenia Bulletin 30:193-217, 2004
25. Lehman AF, Steinwachs DM: Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin 24:1-10, 1998 (Pubitemid 28128486)
26. Suppes T, Dennehy EB, Hirschfeld RMA, et al: The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. Journal of Clinical Psychiatry 66:870-886, 2005 (Pubitemid 41032829)
27. Sajatovic M, Valenstein M, Blow FC, et al: Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disorders 8:232-241, 2006
28. Svarstad BL, Shireman TI, Sweeney J: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services 52:805-811, 2001 (Pubitemid 32577440)
29. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986
30. Manwani SG, Szilagyi KA, Zablotsky B, et al: Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. Journal of Clinical Psychiatry 68:1172-1176, 2007 (Pubitemid 47395618)
31. Busch AB, Huskamp HA, Neelon B, et al: Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorder. Medical Care 47:1217-1228, 2009
32. Busch AB, Lehman AF, Goldman HH, et al: Changes over time and disparities in schizophrenia treatment quality. Medical Care 44:199-208, 2009
33. Swartz MS, Wilder CM, Swanson JW, et al: Assessing outcomes for consumers in New York's assisted outpatient treatment program. Psychiatric Services 61:976-981, 2010
34. Farris C, Brems C, Johnson ME, et al: A comparison of schizophrenic patients with or without coexisting substance use disorder. Psychiatric Quarterly 74:205-222, 2003 (Pubitemid 38115316)
35. Kirchner JE, Owen RR, Nordquist C, et al: Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatric Services 49:82-85, 1998 (Pubitemid 28049062)
36. Drake RE, Osher FC, Wallach MA: Alcohol use and abuse in schizophrenia: a prospective community study. Journal of Nervous and Mental Disease 177:408-414, 1989 (Pubitemid 19185431)
37. Swofford CD, Scheller-Gilkey G, Miller AH, et al: Double jeopardy: schizophrenia and substance use. American Journal on Drug and Alcohol Abuse 26:343-353, 2000 (Pubitemid 30667001)